Why this ‘Magnificent 7’ stock is still a buy even though it’s behind on AI

Why this ‘Magnificent 7’ stock is still a buy even though it’s behind on AI




Source

Fed’s Goolsbee calls for a hold on cuts as current rate of inflation is ‘not good enough’
World

Fed’s Goolsbee calls for a hold on cuts as current rate of inflation is ‘not good enough’

Austan Goolsbee, president and chief executive officer of the Federal Reserve Bank of Chicago, speaks during the National Association of Business Economics (NABE) economic policy conference in Washington, DC, US, on Tuesday, Feb. 24, 2026. Graeme Sloane | Bloomberg | Getty Images Chicago Federal Reserve President Austan Goolsbee said Tuesday that interest rate cuts aren’t […]

Read More
Novo Nordisk to slash GLP-1 list prices by up to 50% in U.S. to cut costs for insured patients
World

Novo Nordisk to slash GLP-1 list prices by up to 50% in U.S. to cut costs for insured patients

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, Feb. 4, 2026. Tom Little | Reuters Novo Nordisk on Tuesday said it plans to slash the monthly list prices of its popular obesity and diabetes drugs in the U.S. by up to 50% starting in 2027, […]

Read More
Shares of private credit poster child Blue Owl are falling after a downgrade
World

Shares of private credit poster child Blue Owl are falling after a downgrade

Deutsche Bank sees shares of Blue Owl Capital stagnating from here, citing slower fee-related earnings growth, as the private credit poster child’s struggles continue. Analyst Brian Bedell downgraded the stock to hold from buy. He also slashed his price target to $10 from $15, which implies downside of 4%. Shares of Blue Owl have plunged […]

Read More